BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Crexont (IPX203) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Crexont (IPX203)\, from ClinicalTrials.go
 v estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07138560-1572@assetmemo.bio
DTSTAMP:20261121T005020Z
DTSTART;VALUE=DATE:20270215
DTEND;VALUE=DATE:20270216
SUMMARY:Crexont (IPX203): Phase 4 readout est. (NCT07138560)
DESCRIPTION:Crexont (IPX203)\, phase 4\, Parkinson's Disease.\nStudy: BOOST
 -PD A Naturalistic Study on IPX-203 for Parkinson's Disease\nEstimated pri
 mary completion: 15 February 2027. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/crexont-ipx203#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07138560
URL:https://assetmemo.bio/drug/crexont-ipx203#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
